Type
. Chemotherapy of leprosy. Lancet (London, England). 1982;2(8296):490.
Type
. In vitro stimulation of lymphocytes in leprosy patients, healthy contacts of leprosy patients, and subjects not exposed to leprosy. Comparison of an antigen fraction prepared from Mycobacterium leprae and tuberculin-purified protein derivative. Scandinavian journal of immunology. 1982;16(2):103-15.
Type
Chemotherapy of leprosy. Lancet (London, England). 1982;2(8289):77-80.
Type
. Congenital absence of sensation. Its differential diagnosis. Leprosy in India. 1982;54(3):499-504.
Type
. Defect in the generation of cytotoxic T cells in lepromatous leprosy. Clinical and experimental immunology. 1982;48(3):633-40.
Type
. Study of renal changes in leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1982;50(2):143-7.
Type
. Once-monthly rifampicin plus daily dapsone in initial treatment of lepromatous leprosy. Lancet (London, England). 1982;1(8283):1199-202.
Type
. A new urinary metabolite of clofazimine in leprosy patients. Drug metabolism and disposition: the biological fate of chemicals. 1982;10(3):286-8.
Type
. A preliminary report on sub-clinical infection in leprosy. Leprosy in India. 1982;54(2):220-7.
Type
. Hypothesis: erythema nodosum leprosum is precipitated by an imbalance of T lymphocytes. Leprosy review [Internet]. 1982;53(1):1-7. Available from: http://leprev.ilsl.br/pdfs/1982/v53n1/pdf/v53n1a01.pdf